Plasmid-mediated colistin resistance in pathogenic bacteria
Main Article Content
Keywords
Colistin, MCR Genes, Plasmids, Enterobacteriaceae, Molecular Epidemiology
Abstract
Abstract
Plasmid-mediated mcr colistin resistance has emerged as a growing global health threat by undermining one of the last therapeutic options against multidrug-resistant Gram-negative bacilli. This study provides a systematic and critical review of literature published between 2015 and 2025, including PubMed, Scopus, GenBank, and World Health Organization (WHO) reports. We analyzed the global distribution, prevalence, genetic variants, molecular mechanisms, diagnostic tools, and clinical implications of mcr. Findings reveal widespread dissemination across humans, animals, and the environment, with the highest burden in Asia and an alarming increase in Latin America. Variants such as mcr-3 and mcr-9 are particularly concerning due to their coexistence with carbapenemase genes, raising the risk of pan-resistant strains. Clinically, these infections are associated with high mortality, prolonged hospital stays, and increased costs, while asymptomatic intestinal carriage facilitates silent spread. Strengthening microbiological and genomic surveillance, implementing rapid diagnostic methods, regulating polymyxin use, and fostering novel therapeutic alternatives are urgently needed. Plasmid-mediated colistin resistance should not be seen as an isolated phenomenon but as a complex clinical, epidemiological, and social challenge requiring immediate and coordinated action to prevent a post-antibiotic era.
References
1. Puri B, Vaishya R, Vaish A. Antimicrobial resistance: current challenges and future directions. Med J Armed Forces India. 2025;81(3):247-58. doi: 10.1016/j.mjafi.2024.07.006
2. World Health Organization. 2025 edition of global survey to track antimicrobial resistance launches. Geneva: WHO; May 15 2025.
3. Yang S, Slingerland CJ, Nang SC, et al. Polymyxins: recent advances and challenges. Trends Microbiol. 2024;32(8). doi: 10.1016/j.tim.2024.03.008
4. Aslan AT, Akova M, Paterson DL. Next-generation polymyxin class of antibiotics: a ray of hope illuminating a dark road. Antibiotics. 2022;11(12):1711. doi: 10.3390/antibiotics11121711
5. Tuon FF, Rocha JL, Gasparetto J. Polymyxin B and colistin—the economic burden of nephrotoxicity against multidrug resistant bacteria. J Med Econ. 2019;22(2):158-62. doi: 10.1080/13696998.2018.1552431
6. Mondal AH, Khare K, Saxena P, et al. A review on colistin resistance: an antibiotic of last resort. Microorganisms. 2024;12(4):772. doi: 10.3390/microorganisms12040772
7. Bakleh MZ, Kohailan M, Marwan M, et al. A systematic review and comprehensive analysis of mcr gene prevalence in bacterial isolates in Arab countries. Antibiotics. 2024;13(10):958. doi: 10.3390/antibiotics13100958
8. Mmatli M, Mbelle NM, Osei Sekyere J. Global epidemiology, genetic environment, risk factors and therapeutic prospects of mcr genes: a current and emerging update. Front Cell Infect Microbiol. 2022;12:941358. doi: 10.3389/fcimb.2022.941358
9. Yang T, Li W, Cui Q, et al. Distribution and transmission of colistin resistance genes mcr-1 and mcr-3 among nontyphoidal Salmonella isolates in China from 2011 to 2020. Microbiol Spectr. 2023;11(1):e0383322. doi: 10.1128/spectrum.03833-22
10. Zhuang Y, Li X, Wu Y, et al. Colistin resistance landscape: insights into the global spread of mcr-carrying Gram-negative bacteria. Int J Antimicrob Agents. 2024;64(2):107207. doi: 10.1016/j.ijantimicag.2024.107207
11. Pellegrini JL, González Á, Lösch LS, et al. Colistin-resistant Escherichia coli mediated by the mcr-1 gene from pigs in northeastern Argentina. Rev Argent Microbiol. 2025. doi: 10.1016/j.ram.2024.12.013
12. Galindo-Méndez M, Navarrete-Salazar H, Pacheco-Vásquez R, et al. Detection of plasmid-mediated resistance against colistin in multidrug-resistant Gram-negative bacilli isolated from a tertiary hospital. Microorganisms. 2023;11(8):1996. doi: 10.3390/microorganisms11081996
13. Amabile-Cuevas CF. Antibiotic usage and resistance in Mexico: an update after a decade of change. J Infect Dev Ctries. 2021;15(4):442-9. doi: 10.3855/jidc.13467
14. Anyanwu MU, Okpala COR, Chah KF, et al. Prevalence and traits of mobile colistin resistance gene harbouring isolates from different ecosystems in Africa. Biomed Res Int. 2021;2021:6630379. doi: 10.1155/2021/6630379
15. Bastidas-Caldes C, de Waard JH, Salgado MS, et al. Worldwide prevalence of mcr-mediated colistin-resistance Escherichia coli in isolates of clinical samples, healthy humans, and livestock: a systematic review and meta-analysis. Pathogens. 2022;11(6):659. doi: 10.3390/pathogens11060659
16. Wang C, Feng Y, Liu L, et al. Identification of novel mobile colistin resistance gene mcr-10. Emerg Microbes Infect. 2020;9(1):508-16.
17. Song K, Cao H, Lu J, et al. Decoding the origins, spread, and global risks of mcr-9 gene. Microbiol Spectr. 2024;12(1):e01462-23. doi: 10.1128/spectrum.01462-23
18. Smelikova E, Tkadlec J, Krutova M. How to: screening for mcr-mediated resistance to colistin. Clin Microbiol Infect. 2022;28(1):43-50. doi: 10.1016/j.cmi.2021.09.009
19. Simner PJ, Bergman Y, Trejo M, et al. Multicenter evaluation of colistin broth disk elution and colistin agar test: a report from the Clinical and Laboratory Standards Institute. J Clin Microbiol. 2019;57(11):e01269-19. doi: 10.1128/JCM.01269-19
20. Osei Sekyere J, Sephofane AK, Mbelle NM. Comparative evaluation of CHROMagar COL-APSE, MicroScan Walkaway, ComASP Colistin, and Colistin MAC Test in detecting colistin-resistant Gram-negative bacteria. Sci Rep. 2020;10:6221. doi: 10.1038/s41598-020-63267-2
21. Wang X, Wang Y, Zhou Y, et al. Validation of a tenfold multiplex PCR method for simultaneous detection of mcr-1 to mcr-10 colistin resistance genes. J Vet Diagn Invest. 2021;33(2):288-93. doi: 10.1177/1040638720982662
22. Furniss RCD, Dortet L, Bolland W, et al. Detection of colistin resistance in Escherichia coli by use of the MALDIxin test, based on MALDI-TOF mass spectrometry. J Clin Microbiol. 2019;57(12). doi: 10.1128/JCM.01427-19
23. Osei Sekyere J. Mcr colistin resistance gene: a systematic review of current diagnostics and detection methods. Microbiologyopen. 2019;8(4):e00682. doi: 10.1002/mbo3.682
24. Sanikhani R, Akbari M, Hosseinzadeh M, et al. Outbreak of colistin- and carbapenem-resistant Klebsiella pneumoniae ST16 co-producing NDM-1 and OXA-48 isolates in an Iranian hospital. BMC Microbiol. 2024;24:59. doi: 10.1186/s12866-024-03207-6
25. Vlad MA, Ianoşi G, Gherghel P, et al. Colistin resistance in Gram-negative bacteria during the COVID-19 pandemic: clinical outcomes and mortality risk. Antibiotics. 2025;14(3):275. doi: 10.3390/antibiotics14030275
26. Theuretzbacher U, Bush K, Harbarth S, et al. Critical analysis of antibacterial agents in clinical development. Nat Rev Microbiol. 2020;18(5):286-98. doi: 10.1038/s41579-019-0288-0
27. Chirabhundhu N, Luk-In S, Phuadraksa T, et al. Occurrence and mechanisms of tigecycline resistance in carbapenem- and colistin-resistant Klebsiella pneumoniae in Thailand. Sci Rep. 2024;14:5215. doi: 10.1038/s41598-024-55705-2
28. Anthony WE, Johnson JR, Jeraldo P, et al. The gut microbiome as a reservoir for antimicrobial resistance: current knowledge and future challenges. Front Microbiol. 2020;11:1342. doi: 10.3389/fmicb.2020.01342
29. Murray CJL, Ikuta KS, Sharara F, et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399(10325):629-55.
30. Ahmed MO, Abouzeed YM, Ali Daw M, et al. Global initiatives to phase-out colistin use in food-producing animals. Open Vet J. 2025;15:100-8. doi: 10.5455/ovj.227387
31. Luo Q, Wang Y, Xiao Y. Prevalence and transmission of mobilized colistin resistance (mcr) gene in bacteria common to animals and humans. Biosaf Health. 2020;2(2):71-8. doi: 10.1016/j.bsheal.2020.05.001
32. Chatzidimitriou M, Kavvada A, Kavvadas D, et al. mcr genes conferring colistin resistance in Enterobacterales: a five year overview. Acta Med Acad. 2021;50(3):365-71. doi: 10.5644/ama2006-124.355
33. Norma Oficial Mexicana NOM-045-SSA2-2005, para la vigilancia epidemiológica, prevención y control de las infecciones nosocomiales. México: Diario Oficial de la Federación; 2005.
34. Comisión Federal para la Protección contra Riesgos Sanitarios. Lineamientos para la regulación del uso de antimicrobianos en medicina veterinaria. México: COFEPRIS; 2022.
35. Secretaría de Salud. Estrategia Nacional contra la Resistencia a los Antimicrobianos (ENCRA) 2018-2024. México: Secretaría de Salud; 2018
Article Sidebar
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Authors retain their copyright and grant the Revista Médica del IMSS the right of first publication. Articles are distributed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which allows sharing as long as the author and the original source are properly credited.